A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 91,878 shares of LLY stock, worth $71.5 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
91,878
Previous 92,898 1.1%
Holding current value
$71.5 Million
Previous $84.1 Million 3.22%
% of portfolio
1.92%
Previous 2.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $787,582 - $979,220
-1,020 Reduced 1.1%
91,878 $81.4 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $2.71 Million - $3.39 Million
-3,734 Reduced 3.86%
92,898 $84.1 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $1.59 Million - $2.13 Million
-2,685 Reduced 2.7%
96,632 $75.2 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $5.57 Million - $6.57 Million
10,606 Added 11.96%
99,317 $57.9 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $828,538 - $1.14 Million
-1,906 Reduced 2.1%
88,711 $47.6 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $440,178 - $588,569
-1,255 Reduced 1.37%
90,617 $42.5 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $788,068 - $925,548
2,537 Added 2.84%
91,872 $31.6 Million
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $100,645 - $117,271
-313 Reduced 0.35%
89,335 $0
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $643,361 - $733,177
2,170 Added 2.48%
89,648 $29 Million
Q2 2022

Aug 01, 2022

SELL
$278.73 - $327.27 $377,679 - $443,450
-1,355 Reduced 1.53%
87,478 $28.4 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $993,208 - $1.23 Million
-4,232 Reduced 4.55%
88,833 $25.4 Million
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $101,632 - $126,126
-452 Reduced 0.48%
93,065 $25.7 Million
Q3 2021

Nov 29, 2021

BUY
$221.6 - $272.71 $20.7 Million - $25.5 Million
93,517 New
93,517 $21.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Badgley Phelps Wealth Managers, LLC Portfolio

Follow Badgley Phelps Wealth Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.